This paper aimed to describe the use of a new technology, RUBINA™, to perform intra-operative ICG fluorescent cholangiography (FC) in pediatric LC. ICG-FC was performed during LC using the new technology RUBINA™ in two pediatric surgery units. The ICG dosage was 0.35 mg/Kg and the median timing of administration was 15.6 h prior to surgery. Patient baseline, intra-operative details, rate of biliary anatomy identification, utilization ease, and surgical outcomes were assessed. Results showed that the new RUBINA™ technology was very effective to perform ICG-FC during LC in pediatric patients allowing surgeons fluorescence imaging of the target anatomy to assess position of critical biliary structures or presence of anatomical anomalies to safely perform the operation.
https://link.springer.com/article/10.1007/s00464-021-08596-7
